BioNTech Founders in Dialogue with TÜBİTAK to Invest in Turkey

​​​​Germany-based scientist Dr. Uğur Şahin, the Pfizer and BioNTech COVID-19 vaccine developer along with Dr. Özlem Türeci, has been in a dialogue with the Scientific and Technological Research Council of Turkey (TÜBİTAK) to launch a cancer research center in his home country Turkey. 

TÜBİTAK made an offer to BioNTech – founded by Şahin and Türeci in Germany – to set up jointly a medical research center in Turkey, announced Minister of Industry and Technology Mustafa Varank during his interview with Anadolu Agency. Minister Varank said, “Şahin wants to study on cancer research, and he maintains discussions with our Ministry officials to invest in Turkey.”

Emphasizing that it would be more than a pleasure to host Şahin and Türeci in Turkey for medical research, Minister Varank added, “We gave them detailed information on the capabilities of both public and private institutions in our country.” 
Uğur Şahin and BionTech Company Logo
BioNTech; Uğur Şahin; Özlem Türeci; Pfizer; COVID-19; vaccine; investment; cancer